THE EMERGING ROLE OF SERRATIOPEPTIDASE IN ORAL SURGERY: LITERATURE UPDATE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i3.23471Keywords:
Analgesic, Anti-inflammatory, Oral surgery, Infections, Proteolytic enzymes, Serrapeptase, Serratiopeptidase, Third molar surgeryAbstract
 Serratiopeptidase, a proteolytic enzyme derived from Serratia E-15 species enterobacteria, is widely used in medical field for its anti-inflammatory, anti-edemic properties, and analgesic properties. It is being used commonly in various specialties such as orthopedics, otolaryngology, gynecology, surgery, pulmonology, ophthalmology, and dentistry. Research has shown that serratiopeptidase is the most effective anti-inflammatory agent compared to other enzyme preparations. This article reviews the efficacy, safety, and applications of serratiopeptidase in oral surgery. This article also discusses the mechanism of action of serratiopeptidase, its contraindications and complications. From the recently published literature, it is clear that the role of serratiopeptidase as a therapeutic agent in oral and maxillofacial surgery is expanding and they hold a promising future as a broad-spectrum anti-inflammatory drug with minimal side effects and complications. Further, research will broaden their applications in the field of medicine and dentistry.
Downloads
References
Sherry S, Fletcher AP. Proteolytic enzymes: A therapeutic evaluation. Clin Pharmacol Ther 1960;1:202-26.
Ambrus JL, Lassman HB, DeMarchi JJ. Absorption of exogenous and endogenous proteolytic enzymes. Clin Pharmacol Ther 1967;8:362-8.
Yamasaki H, Tsuji H, Saeki K. Anti-inflammatory action of a protease, TSP, produced by Serratia. Nihon Yakurigaku Zasshi 1967;63:302 14.
Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: A multicentre, double-blind, randomized trial versus placebo. J Int Med Res 1990;18:379-88.
Kakinuma A, Moriya N, Kawahara K, Sugino H. Repression of fibrinolysis in scalded rats by administration of Serratia protease. Biochem Pharmacol 1982;31:2861-6.
Miyata K, Maejima K, Tomoda K, Isono M. Serratia protease Part I. Purification and general properties of the enzyme. Agric Biol Chem 1970;34:310-8.
Kaviyarasi NS, Prashantha CN, Suryanarayan VV. In silico analysis of inhibitor and substrate binding site of serrapeptidase from Serratia marcescens MTCC 8708. Int J Pharm Pharm Sci 2016;8:975-1491.
Indrayati A, Asyarie S, Suciati T, Retnoningrum DS. Study on the properties of purified recombinant superoxide dismutase from Staphylococcus equorum, a local isolate from Indonesia. Int J Pharm Pharm Sci. 2014;6(11):1-6.
Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee IS, Hase T, et al. Cloning and sequencing of Serratia protease gene. Nucleic Acids Res 1986;14:5843-55.
Jadav SP, Patel NH, Shah TG, Gajera MV, Trivedi HR, Shah BK, et al. Comparison of anti-inflammatory activity of Serration peptidase and diclofenac in albino rats. J Pharmacol Pharmacother 2010;1:116-7.
Kaur H, Singh A. Design, development and characterization of Serration peptidase loaded albumin nanoparticles. J App Pharm Sci 2015;5:103-9.
Malshe PC. Orally administered Serration peptidase: Can it work? J Assoc Physicians India 1998;46:492.
Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, et al. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem 1994;20:101-8.
Moriya N, Shoichi A, Yoko H, Fumio H, Yoshiaki K. Intestinal absorption of serrapeptase and its distribution to the inflammation sites. Jpn Pharmacol Ther 2003;31:659-66.
Yamasaki H, Tsuji H, Saeki K. Anti-inflammatory action of a protease, TSP, produced by Serratia. Nihon Yakurigaku Zasshi 1967;63:302-14.
Heumann D, Vischer TL. Immunomodulation by alpha 2-macroglobulin-protease complexes: The effect on the human T-lymphocyte response. Eur J Immunol 1988;18:755.
Desser L, Rehberger A. Induction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes. Oncology 1990;47:475-7.
Hale LP, Haynes BF. Bromelain treatment of human T-cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, and Leu81/LAM 1 surface molecules and markedly enhances CD2 mediated T-cell activation. J Immunol 1992;149:3809.
LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. Lab Invest 1991;65:3-14.
Desser L, Rehberger A, Kokron E, Paukovits W. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 1993;50:403-7.
Nakamura S, Hashimoto Y, Mikami M, Yamanaka E, Soma T, Hino M, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology 2003;8:316-20.
Braga PC, Moretti M, Piacenza A, Montoli CC, Guffanti EE. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo. Int J Clin Pharmacol Res 1993;13:179-85.
Selan L, Papa R, Tilotta M, Vrenna G, Carpentieri A, Amoresano A, et al. Serratio peptidase: A well-known metalloprotease with a new non-proteolytic activity against S. aureus biofilm. BMC Microbiol 2015;15:207.
Longhi C, Scoarughi GL, Poggiali F, Cellini A, Carpentieri A, Seganti L, et al. Protease treatment affects both invasion ability and biofilm formation in Listeria monocytogenes. Microb Pathog 2008;45:45-52.
Artini M, Scoarughi GL, Papa R, Cellini A, Carpentieri A, Pucci P, et al. A new anti-infective strategy to reduce adhesion-mediated virulence in Staphylococcus aureus affecting surface proteins. Int J Immunopathol Pharmacol 2011;24:661-72.
Papa R, Artini M, Cellini A, Tilotta M, Galano E, Pucci P, et al. A new anti-infective strategy to reduce the spreading of antibiotic resistance by the action on adhesion-mediated virulence factors in Staphylococcus aureus. Microb Pathog 2013;63:44-53.
Mecikoglu M, Saygi B, Yildirim Y, Karadag-Saygi E, Ramadan SS, Esemenli T, et al. The effect of proteolytic enzyme Serration peptidase in the treatment of experimental implant-related infection. J Bone Joint Surg Am 2006;88:1208-14.
Joshi KK, Nerurkar RP. Anti-inflammatory effect of the Serration peptidase – rationale or fashionable: A study in rat paw oedema model induced by the carrageenan. Indian J Physiol Pharmacol 2012;56:367 74.
Moitra S, Sen S, Banerjee I, Das P, Tripathi SK. Diclofenac- Serratio peptidase combination induced stevens – Johnson syndrome - A rare case report with review of literature. J Clin Diagn Res 2014;8:8-11.
Rajaram P, Bhattacharjee A, Ticku S. Serratio peptidase - A cause for spread of infection. J Clin Diagn Res 2016;10:ZD31-2.
Bhagat S, Agarwal M, Roy V. Serratio peptidase: A systematic review of the existing evidence. Int J Surg 2013;11:209-17.
Tiwari M. The role of Serratio peptidase in the resolution of inflammation. Asian J Pharm Sci 2017;12:209-15.
Sadanobu K, Shoji T, Nishimura Y, Miyazaki S. Effect of combination therapy with Danzen tablets and antibiotics for acute cystitis. Acta Urol Jpn 1967;13:853-7.
Cooney DA, Rosenbluth RJ. Enzymes as therapeutic agents. Adv Pharmacol Chemother 1975;12:185-289.
Esch PM, Gerngross H, Fabian A. Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase-- a prospective study. Fortschr Med 1989;107:67 8,71-2.
Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with serrapeptase (Danzen): A randomised double-blind controlled trial. Singapore Med J 1989;30:48-54.
Mundhava SG, Mehta DS, Thaker SJ. A comparative study to evaluate anti-inflammatory and analgesic activity of commonly used proteolytic enzymes and their combination with diclofenac in rats. Int J Pharm Sci Res 2016;7:2615.
Viswanatha Swamy AH, Patil PA. Effect of some clinically used proteolytic enzymes on inflammation in rats. Indian J Pharm Sci 2008;70:114-7.
Panagariya A, Sharma AK. A preliminary trial of Serration peptidase in patients with carpal tunnel syndrome. J Assoc Physicians India 1999;47:1170-2.
Al-Khateeb TH, Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. Int J Oral Maxillofac Surg 2008;37:264-8.
Murugesan K, Sreekumar K, Sabapathy B. Comparison of the roles of Serration peptidase and dexamethasone in the control of inflammation and trismus following impacted third molar surgery. Indian J Dent Res 2012;23:709-13.
Chappi DM, Suresh KV, Patil MR, Desai R, Tauro DP, Bharani KN, et al. Comparison of clinical efficacy of methylprednisolone and Serration peptidase for reduction of postoperative sequelae after lower third molar surgery. J Clin Exp Dent 2015;7:e197.
Al-Sandook TA, Tawfik NO, Qassim DA. Clinical evaluation of the efficacy of orthal-forte (prolytic enzymes, trypsin and chymotrypsin) on postoperative sequel following the removal of lower impacted third molar. Int J Enhanc Res Sci Technol Eng 2014;3:169-73.
Chopra D, Rehan HS, Mehra P, Kakkar AK. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, Serration peptidase, ibuprofen and betamethasone using the dental impaction pain model. Int J Oral Maxillofac Surg 2009;38:350-5.
Chaiwat S, Suddhasthira T, Nuntasanti V. Effect of Serratio peptidase on postoperative swelling after removal of impacted mandibular third molar. Mahidol Dent J 1991;11:(e-journal).
Surachai. A Postoperative Study in Dental Patients After Extraction of 3rd Molar; 1981.
Okumura H, Watanabe R, Kotoura Y, Nakane Y, Tangiku O. Effects of a proteolytic-enzyme preparation used concomitantly with an antibiotic in osteoarticular infections (author’s transl). Jpn J Antibiot 1977;30:223-7.
Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, et al. Augmentation by serrapeptase of tissue permeation by cefotiam. Jpn J Antibiot 1986;39:761-71.
Selan L, Berlutti F, Passariello C, Comodi-Ballanti MR, Thaller MC. Proteolytic enzymes: A new treatment strategy for prosthetic infections? Antimicrob Agents Chemother 1993;37:2618-21.
Aratani H, Tateishi H, Negita S. Studies on the distributions of antibiotics in the oral tissues: Experimental staphylococcal infection in rats, and effect of Serration peptidase on the distributions of antibiotics (author’s transl). Jpn J Antibiot 1980;33:623-35.
Ishihara Y, Kitamura S, Takaku F. Experimental studies on distribution of cefotiam, a new beta-lactam antibiotic, in the lung and trachea of rabbits. II. Combined effects with Serration peptidase. Jpn J Antibiot 1983;36:2665-70.
Neubauer RA. A plant protease for potentiation of and possible replacement of antibiotics. Exp Med Surg 1961;19:143.
Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Nakai Y. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica 1984;3:526-30.
Garg R, Aslam S, Garg A, Walia R. A prospective comparative study of Serration peptidase and aceclofenac in upper and lower limb soft tissue trauma cases. Int J Pharmacol Pharm Technol 2012;1:11.
UmaMaheswari T, Hemalatha T, Sankaranarayanan P, Puvanakrishnan R. Enzyme therapy: Current perspectives. Indian J Exp Biol 2016;54:7 16.
Shahid S. Role of systemic enzymes in infections. Webmed Central Complement Med 2012;3:WMC002504.
Maurya P, Bajpai M. Study of secnidazole - Serratio peptidase alginate/HPMC gels for periodontal delivery. Int J PharmTech Res 2011;3:1488 94.
Shah SA, Nerurkar RP. Evaluation of prescribing trends and rationality of use of oral proteolytic enzymes. Indian J Pharmacol 2013;45:309-10.
Kang TS, Stevens RC. Structural aspects of therapeutic enzymes to treat metabolic disorders. Hum Mutat 2009;30:1591-610.
Bannenberg GL. Resolvins: Current understanding and future potential in the control of inflammation. Curr Opin Drug Discov Devel 2009;12:644-58.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
